metipranolol has been researched along with Coronary Disease in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dietmann, K; Sponer, G; Voss, E | 1 |
Broniszewska-Ardelt, B; Ceremuzyński, L; Herbaczyńska-Cedro, K; Woźniewicz, B | 1 |
Kolc, J; Málek, I; Mrhová, O; Urbanová, D | 1 |
Kolc, J; Málek, I; Málek, P | 1 |
Barbanti, P; Cottini, E; Dimaiuta, G; Emma, V; Lunetta, M; Sorrentino, F | 1 |
Glocke, M; Müller, G; Uberbacher, HJ | 1 |
Gasilin, VS; Grigoriants, RA; Lobova, NM; Lupanov, VP | 1 |
Hůla, J; Kubín, Z; Smíd, J | 1 |
Jeschke, J; Kubín, Z; Smíd, J; Zeman, V | 1 |
Kubín, Z; Smíd, J | 1 |
Fabián, J; Janota, M; Rohác, J; Vrána, M | 1 |
Ceremuzynski, L; Nauman, A; Nauman, J; Zaleska, T; Zalewski, A | 1 |
Blazek, Z; Fejfar, Z; Hess, L; Vrána, M; Vránová, Z | 1 |
Bada, V; Gvozdják, J; Gvozdjáková, A; Kucharská, J | 1 |
Fabián, J; Gebauerová, M; Jedlicka, J; Málek, I; Stanĕk, V | 1 |
2 trial(s) available for metipranolol and Coronary Disease
Article | Year |
---|---|
[Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Metipranolol; Middle Aged; Propanolamines | 1983 |
Treatment of ischaemic heart disease with beta-adrenoblocking agents Trimepranol and Obsidan.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Metipranolol; Middle Aged; Physical Exertion; Propanolamines; Propranolol | 1983 |
13 other study(ies) available for metipranolol and Coronary Disease
Article | Year |
---|---|
[Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
Topics: Adrenergic beta-Antagonists; Animals; Coronary Disease; Dogs; Drug Therapy, Combination; Isosorbide Dinitrate; Male; Metipranolol; Propanolamines | 1981 |
Prevention of adrenaline-induced metabolic systemic and myocardial alterations by the beta-blocking agent metipranolol in the dog.
Topics: Adenosine Triphosphatases; Animals; Coronary Disease; Dogs; Epinephrine; Fatty Acids, Nonesterified; Female; Heart; Hydrogen-Ion Concentration; Male; Metabolism; Metipranolol; Myocardium; Propanolamines; Succinate Dehydrogenase; Triiodothyronine | 1981 |
The effect of trimepranol in the ischaemic focus in the dog.
Topics: Animals; Coronary Disease; Coronary Vessels; Creatine Kinase; Dogs; Heart Rate; Ligation; Metipranolol; Propanolamines | 1981 |
[Reperfusion ventricular fibrillation in the dog].
Topics: Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Dogs; Ligation; Metipranolol; Rolitetracycline; Ventricular Fibrillation; Verapamil | 1982 |
[Clinical and metabolic effects of metipranolol].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Disease; Humans; Male; Metipranolol; Middle Aged; Myocardial Infarction; Propanolamines | 1981 |
[Changes in the efficiency of the left heart ventricle during treatment with metipranolol (Trimepranol Spofa)].
Topics: Cardiac Output; Coronary Disease; Heart Ventricles; Humans; Male; Metipranolol; Middle Aged; Myocardial Contraction; Propanolamines; Stroke Volume | 1983 |
[Effect of metipranolol (Trimepranol Spofa) on changes in selected hemodynamic indicators during physical exercise. I. Dynamic loading].
Topics: Coronary Disease; Hemodynamics; Humans; Male; Metipranolol; Middle Aged; Physical Exertion; Propanolamines | 1983 |
[Effect of metipranolol (Trimepranol Spofa) on changes in selected hemodynamic indicators during physical exercise. II. Isometric loading].
Topics: Coronary Disease; Hemodynamics; Humans; Isometric Contraction; Male; Metipranolol; Middle Aged; Muscle Contraction; Propanolamines | 1983 |
[Exercise test with beta receptor blockade in healthy subjects and in patients with ischemic heart disease].
Topics: Adult; Angina Pectoris; Coronary Disease; Exercise Test; Female; Humans; Male; Metipranolol; Middle Aged; Propanolamines | 1978 |
Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Coronary Disease; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Heart Rate; Humans; Hypertension; Hyperthyroidism; Male; Metipranolol; Middle Aged; Propanolamines | 1979 |
Electrical instability of the heart in acute local myocardial ischaemia: pathogenesis and experimental prevention.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Coronary Disease; Dogs; Electrophysiology; Metipranolol; Moricizine; Myocardium; Neurotransmitter Agents; Phenothiazines; Trimecaine; Ventricular Fibrillation | 1986 |
Cardioprotective effect of metipranolol on ischemic heart muscle.
Topics: Animals; Coronary Disease; Dogs; Male; Metipranolol; Mitochondria, Heart; Oxidative Phosphorylation; Oxygen Consumption; Propanolamines | 1989 |
[The simultaneous administration of nifedipine and beta blockers].
Topics: Adult; Coronary Disease; Drug Therapy, Combination; Hemodynamics; Humans; Male; Metipranolol; Middle Aged; Nifedipine; Propanolamines | 1986 |